Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 20 Similar Profiles
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Radiation Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
cancer Physics & Astronomy
Phosphotransferases Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Radiosurgery Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2014 2020

Research Output 2004 2017

  • 634 Citations
  • 14 Scopus h-Index
  • 28 Article
  • 2 Comment/debate
  • 1 Review article
radiation therapy
cancer
Hepatocellular Carcinoma
Radiotherapy
pathology

Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes

Samuels, S. E., Stenmark, M. H., Lee, J. Y., McHugh, J. B., Hayman, J. A., Orringer, M. B., Urba, S. G., Sun, L., Xie, C., Kong, F. M. & Cuneo, K. C. Jul 1 2017 In : Advances in Radiation Oncology. 2, 3, p. 308-315 8 p.

Research output: Research - peer-reviewArticle

Chemoradiotherapy
Esophageal Neoplasms
Mortality
Therapeutics
Survival
2 Citations

Quantitative Proteomic Analysis of Serum Exosomes from Patients with Locally Advanced Pancreatic Cancer Undergoing Chemoradiotherapy

An, M., Lohse, I., Tan, Z., Zhu, J., Wu, J., Kurapati, H., Morgan, M. A., Lawrence, T. S., Cuneo, K. C. & Lubman, D. M. Apr 7 2017 In : Journal of Proteome Research. 16, 4, p. 1763-1772 10 p.

Research output: Research - peer-reviewArticle

Exosomes
Chemoradiotherapy
Pancreatic Neoplasms
Proteomics
Serum
31 Citations

A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer

Whitley, M. J. , Cardona, D. M. , Lazarides, A. L. , Spasojevic, I. , Ferrer, J. M. , Cahill, J. , Lee, C. L. , Snuderl, M. , Blazer, D. G. , Hwang, E. S. , Greenup, R. A. , Mosca, P. J. , Mito, J. K. , Cuneo, K. C. , Larrier, N. A. , O'Reilly, E. K. , Riedel, R. F. , Eward, W. C. , Strasfeld, D. B. , Fukumura, D. & 6 others Jain, R. K., Lee, W. D., Griffith, L. G., Bawendi, M. G., Kirsch, D. G. & Brigman, B. E. Jan 6 2016 In : Science Translational Medicine. 8, 320, 320ra4

Research output: Research - peer-reviewArticle

Clinical Trials, Phase I
Fluorescent Dyes
Peptide Hydrolases
Neoplasms
Fluorescence
2 Citations

Dissociation of gemcitabine chemosensitization by CHK1 inhibition from cell cycle checkpoint abrogation and aberrant mitotic entry

Parsels, L. A., Tanska, D. M., Parsels, J. D., Zabludoff, S. D., Cuneo, K. C., Lawrence, T. S., Maybaum, J. & Morgan, M. A. Mar 3 2016 In : Cell Cycle. 15, 5, p. 730-739 10 p.

Research output: Research - peer-reviewArticle

gemcitabine
Cell Cycle Checkpoints
3-(carbamoylamino)-5-(3-fluorophenyl)-N-(3-piperidyl)thiophene-2-carboxamide
Pancreatic Neoplasms
roscovitine